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Abstract
Matrix metalloprotease-2 (MMP-2) has the capacity to degrade cartilage extracellular matrix molecules, the turnover of which is an essential
event in chondrogenesis. Here, we investigated the functional role of MMP-2 in chondrogenesis of leg bud mesenchymal cells. Small interference
RNA (siRNA)-mediated knockdown of mmp-2 promoted precartilage condensation and chondrogenesis. Treatment with bafilomycin A1, an
MMP-2 activator, or GM6001, an MMP inhibitor, at the pre-condensation stage resulted in the inhibition or promotion of chondrogenesis,
respectively. By comparison, treatment at the post-condensation stage had little or no effect on chondrogenesis. These results indicate that MMP-2
is involved in the regulation of cell condensation. Inhibition of MMP-2 activity by mmp-2 specific siRNA increased the protein level of
fibronectin, and integrins α5 and β1. The interaction between focal adhesion kinase (FAK) and integrin β1 leading to tyrosine phosphorylation of
FAK was also enhanced. Moreover, inactivation of p38MAPK down-regulated the level of MMP-2 mRNA and activity, and increased
mesenchymal cell condensation in parallel with enhanced phosphorylation of FAK. Taken together, our data indicate that MMP-2 mediates the
inhibitory signals of p38MAPK during mesenchymal cell condensation by functioning as a negative regulator of focal adhesion activity regulated
by FAK via interactions with fibronectin through integrin β1.
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Chondrogenesis is a prerequisite event for cartilage forma-
tion in the developing limb, involving mesenchymal cell
recruitment/migration, condensation of progenitors, and chon-
drocyte differentiation and maturation (Goldring et al., 2006;
Olsen et al., 2000). Precartilage condensation forming the
cartilaginous template of the future skeleton is a critical step in
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doi:10.1016/j.ydbio.2007.06.003cell adhesion molecule, N-cadherin, and extracellular matrix
(ECM) molecules including fibronectin, proteoglycans, and
collagens (DeLise et al., 2000; Johnson and Tabin, 1997;
Knudson and Knudson, 2001; Knudson et al., 1999; Sandell
and Adler, 1999). ECM molecules interact with cell adhesion
molecules to activate intracellular signaling pathways involving
focal adhesion kinase (FAK) and to initiate the transition of
chondroprogenitor cells to fully committed chondrocytes (Bang
et al., 2000; DeLise et al., 2000).
Modulation of cell–matrix interactions occurs through the
action of unique proteolytic systems responsible for hydrolysis
of a variety of ECM components. Matrix metalloproteinases
(MMPs) are a major group of enzymes that regulate cell–matrix
composition through the turnover of ECMs and function as key
regulators of cell–ECM interactions during development and
differentiation (Mannello et al., 2005a; Mott and Werb, 2004;
Scheme 1.
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involved in many pathological conditions including rheumatoid
arthritis, cancer, and defective wound healing by regulating the
integrity and composition of the ECM structure (Mannello et
al., 2005b; Nelson and Tien, 2006; Sakai et al., 2001).
The MMPs are Ca2+- and Zn2+-dependent endoproteinases
classified into three subgroups on the basis of substrate
specificity: interstitial collagenases, stromelysins, and gelati-
nases (Visse and Nagase, 2003; Woessner and Nagase, 2000).
MMP-2 is a gelatinase secreted as a 72-kDa precursor and is
processed to an active 62- to 64-kDa form (Aimes and Quigle,
1995; Werb and Chin, 1998). MMP-2 has the capacity to
degrade ECM molecules, including gelatins, fibronectin,
laminin, aggrecan, and collagen I, IV, V, VII and X
(McCawley and Matrisian, 2001; Nagase and Woessner,
1999; Visse and Nagase, 2003). MMP-2 is expressed at high
levels in myoblasts, skeletal muscle satellite cells, Schwann
cells of peripheral nerves, neural crest cells of avian embryos,
and in differentiating adipocytes, suggesting a critical role for
this enzyme in myogenesis, neurogenesis, and adipogenesis
(Bouloumie et al., 2001; Duong and Erickson, 2004; El
Fahime et al., 2000; Guerin and Holland, 1995; Krekoski et al.,
2002). The detection of high levels of MMP-2 in osteoarthritic
cartilage and synovial fluid suggests involvement of MMP-2 in
the degradation of cartilage ECM (Imai et al., 1997; Mohtai et
al., 1993; Tanaka et al., 2000). Consistent with this hypothesis,
testican-1, an inhibitor of pro-MMP-2 activation, is expressed
in joint and growth plate cartilage (Hausser et al., 2004).
Together, these findings suggest that MMP-2 participates in the
regulation of matrix turnover in cartilage and chondrogenic
differentiation.
In the present study, we investigated the functional role of
MMP-2 in chondrogenic differentiation using cultured chick leg
bud mesenchymal cells. MMP-2 was found to function as a
negative regulator of the integrin β1-mediated interaction
between fibronectin and FAK at the focal adhesion site during
cellular condensation. In summary, we propose that the
p38MAPK signal transduction pathway downregulates tyrosine
phosphorylation of FAK by upregulating the level of transcrip-
tion and activation of MMP-2, thereby leading to inhibition of
condensation of leg bud mesenchymal cells.Materials and methods
Cell culture and treatment
Mesenchymal cells derived from the distal tips of leg buds from
Hamburger–Hamilton (HH, Hamburger and Hamilton, 1951) stage 22/23
embryos of fertilized white Leghorn chicken eggs, were micromass-cultured as
described previously (Jin et al., 2006). Cells at 2×107 cells/ml were plated onto
35 or 60 mm dishes in 3 or 19 drops of 15 μl each. The cells were incubated for
1 h at 37 °C under 5% CO2 to allow attachment and were maintained in Ham's
F-12 medium containing 10% fetal bovine serum, 100 IU/ml penicillin, and
50 μg/ml streptomycin (Gibco Invitrogen, Grand Island, NY). The cells were
treated with 3 μMGM6001 (Chemicon, Temecula, CA), 10 nM bafilomycin A1
(Chemicon), 10 μM PD98059, 10 μM SB203580 (Calbiochem, San Diego,
CA), 100 ng/ml insulin-like growth factor-1 (Gropep. Adelaide, Australia),
10 μg/ml herbimycin A, or 5 μg/ml cytochalasin D (Sigma, St. Louis, MO)
unless the concentration is indicated.Analysis of cell condensation and differentiation
Chondrogenic differentiation was measured by Alcian blue staining of
sulfated cartilage glycosaminoglycans (GAG). To demonstrate the deposition of
cartilage matrix proteoglycans, representative cultures were collected at day 5 of
incubation and stained with 0.5%Alcian blue 8GX, pH 1.0 (Hassel and Horigan,
1982; Lev and Spicer, 1964). Alcian blue bound to sulfated GAG was extracted
with 6 M guanidine–HCl, and quantified by measuring the absorbance of the
extracts at 600 nm. Binding of peanut agglutinin (PNA) was used as a specific
marker for precartilage condensation (Maleski and Knudson, 1996). Briefly,
cultures were rinsed twice with 0.02 M PBS, pH 7.2, fixed in methanol:acetone
(1:1) for 1 min, air-dried, and then incubated with 100 μg/ml biotinylated PNA
(Sigma) for 1 h. PNA binding was visualized using the VECTASTAIN ABC and
DAB substrate solution kit (Vector laboratories Inc., Burlingame, CA).
Knockdown of mmp-2 mRNA
To generate constructs encoding small interfering RNA (siRNA) for
mmp-2, oligonucleotides containing 60 nucleotides were synthesized as
shown in Scheme 1, where “mmp-2: sense” and “mmp-2: antisense”
represents 19 nucleotide sequences linked by a hair pin structure. The 19
nucleotide sequence for three different mmp-2 specific antisense was
siRNA-1; 5′-GTGCAATACCTGAATAAAT-3′ (nucleotide no. 273–292),
siRNA-2; 5′-ACTGAGATTTAACCGAATA-3′ (nucleotide no. 590–609), si
RNA-3; 5′-AGGCAGACATTATGATTAA-3′ (nucleotide no. 619–637), The
oligonucleotides were annealed and then ligated into the pSUPER vector
(Oligoengine, Seattle, WA) digested with BglII and XhoI. Positive clones from
ampicillin resistant colonies were detected by the presence of an EcoRI–HindIII
restriction fragment. Electroporation of mesenchymal cells with the siRNA-
encoding vector was conducted using a square wave generator (BTX-830;
Gentronics, San Diego, CA) with 20 ms, 200 square pulses.Reverse transcription-polymerase chain reaction
Total cellular RNAwas extracted with Trizol (Gibco Invitrogen) and cDNA
was synthesized from 1 μg RNA in 20 μl of master mix for reverse transcription
containing 200 U/μl Superscript III (Invitrogen), 5 mM MgCl2, PCR buffer,
1 mM dNTP, 1 U/μl RNase inhibitor, and 2.5 mM oligo dT in DEPC-treated
distilled water. For semiquantitative PCR, synthesized cDNAs were subjected to
25 cycles of PCR amplification under the following conditions: 94 °C
denaturing for 1 min, 55 °C annealing for 1 min and 72 °C extension for
1 min. PCR products were electrophoresed on a 2.0% agarose gel.
Quantitative real-time PCR reactions were performed using a Roche Light
Cycler (Roche, Switzerland). Synthesis of double stranded DNAwas monitored
using SYBR Green I (Roche Laboratories). The PCR program consisted of an
initial denaturation step at 95 °C for 10 min, followed by 40 cycles of 10 s at
95 °C, 15 s at 60 °C and 17 s at 72 °C. To normalize the output, the expression of
each gene of interest was divided by GAPDH gene expression, a commonly
used housekeeping gene. Data are relative to the time point 12 h of control
culture and are presented as a bar graph with standard deviations. Melting-curve
analyses were done following each PCR to determine the output and detection
quality (i.e., the formation of primer–dimers). Primers used for semiquantitative
and quantitative real-time PCR are listed in Table 1.
Zymography
MMP-2 activity was determined using the gelatin zymography assay with
0.1% gelatin as a substrate in a 10% SDS-polyacrylamide gel. Mesenchymal
cells were incubated in serum free media for 24 h and conditioned media (CM)
was concentrated with 10% trichloroacetic acid precipitation. The precipitate
was dissolved in 1X sample buffer (62.5 mM Tris–HCl, pH 6.8, containing 10%
Glycerol, 2% SDS, and 0.005% Bromophenol Blue) and separated by SDS-
Table 1
Primers Sequence
Semiquantitative PCR primers
mmp-2(F) 5′-ACTCCTGTACAAGTGCAG-3′
mmp-2(R) 5′-ACTCCTGTACAAGTGCAG-3′
gapdh (F) 5′-GATGGGTGTCAACCATGAGAAA-3′
gapdh (R) 5′-ATCAAAGGTG GAAGAATGGCTG-3′
Quantitative real time PCR primers
mmp-2 (F) 5′-TCTGCAAGCACGACATTGTA-3′
mmp-2 (R) 5′-AACTCCATTCCAAGAATCCG-3′
gapdh (F) 5′-AGGCGAGATGGTGAAAGTCG-3′
gapdh (R) 5′-TCTGCCCATTTGATGTTGCT-3′
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three times with 2.5% Triton X-100 in water then incubated with 50 mM Tris
buffer, pH 7.4, containing 0.2% Brij 35, 5 mM CaCl2, and 1 mM NaCl,
overnight at 37 °C in a closed container. Gels were then stained for 30 min with
0.25% Coomassie Blue R-250 in 10% acetic acid and 45% methanol, and
destained for 30 min using an aqueous mix of 20% acetic acid, 20% methanol,
and 17% ethanol. Areas of gelatinase activity were detected as clear bands
against the blue-stained gelatin background.
Immunoprecipitation and immunoblot
Cells were lysed in buffer (50 mM Tris–HCl, pH 7.4, containing 150 mM
NaCl, 1% Nonidet P-40, 0.1% SDS, 0.1% deoxycholic acid, 10 mM NaF,
10 mM Na4P2O7, 0.4 mM Na3VO4, and protease inhibitors) for 30 min on ice.
For Western blot analysis, proteins (30 μg) were separated by SDS-PAGE, and
then probed with the following antibodies; paxillin (Signal Transduction Lab,
Beverly, MA), FAK, pFAK, or Src (Santa Cruz Biotechnologies, Santa Cruz,
CA), GAPDH, integrin α5, or integrin β1 (Chemicon), N-cadherin (BD
Transduction Lab, Franklin Lakes, NJ), and fibronectin (Sigma). For Western
blot analysis of MMPs, membrane fraction or CMwas separated by SDS-PAGE,
and then probed with the following antibodies; MT1-MMP, MT3-MMP, MMP-
1, MMP-2, or MMP-13 (Chemicon). Membrane fractionation to analyze the
level of MT1–MMP and MT3–MMP activity was performed. Briefly,
micromass-cultured cells were sonicated and were centrifuged at 100,000×g
for 1 h. The pellet was extracted with 20 mM Tris–HCl (pH 7.5) containing 1%
SDS and 150 mM NaCl. After centrifugation at 15,000×g for 15 min, the
supernatant was taken as the particulate membrane fraction.
The blots were developed with a peroxidase-conjugated secondary antibody,
and reactive proteins were visualized by the ECL system (Amersham-
Pharmacia, Buckinghamshire, UK). For immunoprecipitation, the cell lysates
were incubated with anti-phospho tyrosine (Santa Cruz Biotech) or integrin β1
antibodies for 2 h at 4 °C, and then with a 50% slurry of protein A-Sepharose for
the next 1 h. Immunocomplexes were eluted by boiling in sample buffer then
were analyzed to SDS-PAGE followed by immunoblotting with antibody
against FAK, c-Src or paxillin.
For analysis of MMP-2 activity MMP-2 protein was isolated from CM
treated with or without SB203580 by using 0.5 μg of antibody against MMP-2.
Immunocomplexes were precipitated by incubation with protein A-Sepharose
for 1 h at 4 °C and analyzed by SDS-PAGE and Western blotting.
Results
Knockdown of MMP-2 stimulates precartilage condensation
and chondrogenesis
To investigate the functional role of MMP-2 during chondro-
genesis, we constructed MMP-2 specific siRNAs and trans-
fected mesenchymal cells by electroporation. Avector encoding
EGFP was used as a transfection control. The transfection effi-
ciency was revealed by fluorescence microscopy to detectexpression of the plasmid-encoded EGFP gene (Fig. 1A upper
panel). Western blot analysis 48 h after transfection revealed that
two siRNAvectors, siRNA-1 and siRNA-2 effectively knocked
down the endogenous mmp-2 mRNA level, but not ectopically
expressed EGFP (Fig. 1A lower panel). Western blot analysis
and gelatin zymography also revealed reduced levels of both the
active and pro-forms of MMP-2 by two different MMP-2
siRNA, siRNA-1 and siRNA-2 but not by siRNA-3 (Fig. 1B).
Chondrogenic differentiation of mesenchymal cells is
regulated at various stages including proliferation of chondro-
blast competent cells, precartilage condensation and formation
of cartilage nodules (DeLise et al., 2000; Knudson and
Knudson, 2001; Quarto et al., 1997). Therefore, we first
examined the effect of siRNA-mediated mmp-2 knockdown on
the growth of mesenchymal cells by assessing cell numbers at
days 1, 3, 5 after transfection. As shown in Fig. 1C, knockdown
of mmp-2 had little or no effect on the proliferation of
chondroblast competent cells. We then examined the effect of
siRNA on cellular condensation and chondrogenic differentia-
tion. Mesenchymal cells were electroporated with the mmp-2
siRNA vector and cultured for 48 h. The effect of MMP-2
specific siRNA-1 and siRNA-2 on precartilage condensation
and chondrogenesis was assessed by peanut agglutinin (PNA)
binding for cellular condensation at day 3, and by Alcian blue
staining for sulfated proteoglycans at day 5, respectively.
Knockdown of endogenous MMP-2 in mesenchymal cells led
to stimulation of precartilage condensation and chondrogenic
differentiation (Fig. 1D). We also used Runx2 siRNA as another
control for rule out of unspecific effect of siRNA. Runx2 siRNA
did not show any effect on chondrogenic differentiation and
condensation (data not shown). These results indicate that
MMP-2 functions to negatively regulate cellular condensation
and chondrogenesis of mesenchymal cells.
MMP-2 is involved in early regulation of chondrogenesis
To confirm the involvement of MMP-2 in the regulation of
chondrogenesis, we tested the effect of an MMP-2 inhibitor or
activator on chondrogenesis. Bafilomycin A1 is an inhibitor of
H+-ATPase. A previous report (Maquoi et al., 2003) showed
that the activity of MT1–MMP on the cell surface is
constitutively down-regulated through a vacuolar H+-ATPase-
dependent degradation process. Blockade of this degradation
caused the accumulation of TIMP-free active MT1–MMP
molecules on the cell surface and pro-MMP-2 activation was
strongly enhanced as a consequence of this impaired degrada-
tion. GM6001 is a hydroxamic acid-based MMP inhibitor,
known to inhibit broad spectrum of MMPs activity in vitro and
in vivo (Hu et al., 2003; Galardy et al., 1994; Solorzano et al.,
1997). It has recently been shown that GM6001 in the 1–10 μM
range inhibits MMP-2 activity in various cell types (Macotela et
al., 2006; Margulis et al., 2005; Shen et al., 2006).
Mesenchymal cells were incubated with bafilomycin A1 (5–
50 nM) or GM6001 (0.5–10 μM) for 24 h and MMP-2 activity
was assessed using the gelatin zymography assay. MMP-2
activity was stimulated by 10 nM bafilomycin A1 and inhibited
significantly by 3 μM GM6001 (Fig. 2A left panel) in
Fig. 1. siRNA-directed knockdown of mmp-2 increases chondrogenesis. Leg bud mesenchymal cells were electroporated with either vector (pSUPER) as a mock or
mmp-2-specific siRNA (siRNA-1, -2, or -3). (A) At 48 h, transfected cells were cytospin adhered to slides, fixed and observed under a microscope (bright field, a,
fluorescent field, b; upper panel). The transfection efficiency was confirmed by Western blotting with anti-GFP antibody and RT-PCR using mmp-2 specific primers at
48 h (lower panel). (B) Proteolytic activity of MMP-2 in conditioned media (CM) was analyzed by Western blotting using an anti-MMP-2 antibody (WB) and gelatin
zymography (Zymo). PC indicates a positive control for MMP-2 activity. (C) The number of viable cells was determined at the indicated days. (D) Cultures were fixed
at days 3 or 5 and stained with PNA (upper panel) or Alcian blue (lower panel), respectively. The data shown are representative of at least four independent
experiments.
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A1 or GM6001 for MMP-2 in this concentration, we tested the
activity of other MMPs. Bafilomycin A1 slightly increased the
activation of MT1–MMP governing the activation of proMMP-
2 (Hernandez-Barrantes et al., 2000; Maquoi et al., 1998),
whereas other MMPs such as MT3–MMP, MMP-3 and MMP-
13 were not significantly regulated by bafilomycine A1 or
GM6001 (Fig. 2A right panel).
Cellular condensation events are mediated by cell–matrix
adhesion molecules including fibronectin, proteoglycans and
collagens, which are cleaved by MMP-2 (DeLise et al., 2000;
Nagase and Woessner, 1999; Visse and Nagase, 2003). To
further investigate the functional role of MMP-2 during
chondrogenesis, we examined the temporal action of MMP-2
on condensation and chondrogenic differentiation. Mesenchy-
mal cells were treated with GM6001 (3 μM) or bafilomycin A1
(10 nM) under different exposure time periods. Exposure ofchondroblast to GM6001 at early stage of chondrogenesis (early
exposure, 0–48 h) gave a 2 fold increase in condensation spots
and cartilage nodules, whereas the early exposure of chondro-
blasts to bafilomycin A1 inhibits cellular condensation and
chondrogenesis (Figs. 2C and B). By comparison, exposure of
chondroblasts to either GM6001 or bafilomycin A1 at late stage
of chondrogenesis (late exposure, 48–72 and 72–96 h) showed
a slight reduction in chondrogenic differentiation (Fig. 2B) or
had little effect on condensation (Fig. 2C). These results suggest
that MMP-2 is involved in regulation of chondrogenesis at the
pre-condensation stage.
MMP-2 activity downregulates tyrosine phosphorylation of
FAK
Precartilage condensation is regulated by cell adhesion
molecules, the extracellular matrix and integrins (Bang et al.,
Fig. 2. MMP-2 is involved in the regulation of chondrogenesis at the pre-condensation stage. Mesenchymal competent cells were prepared as described in Materials
and methods. (A) The cells were treated with various concentrations of bafilomycin A1 (BA) or GM6001 (GM), and cultured for 24 h under serum free conditions.
MMP-2 activity was determined by gelatin zymography (left panel). Changes in the levels of MT1–MMP andMT-3MMP on cell surface and the levels of MMP-3 and
MMP-13 in conditioned media were analyzed by Western blotting using respective antibodies. Memb and CM indicate membrane fraction and conditioned media,
respectively. (B and C) Cells treated with 10 nM of bafilomycin A1 or 3 μM of GM6001 for the early stage (0–48 h) or late stages (48–72 and 72–96 h) in the presence
of 10% FBS were stained with Alcian blue at day 5 (B, left panel) or PNA (C) at day 3 of culture. Quantification of chondrogenesis was determined by measuring the
absorbance of bound Alcian blue at 600 nm (B, right panel). The data shown are representative of at least four independent experiments. ⁎⁎⁎, statistically difference
from control cells (Pb0.001).
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To further investigate the regulation of cellular condensation by
MMP-2, the expression levels of N-cadherin, fibronectin, and
integrins α5 and β1 in mesenchymal cells transfected with the
mmp-2 siRNA vector (siRNA-2) or treated with bafilomycin
A1 were assessed by Western blot analysis. The protein level of
fibronectin, and the integrins α5 and β1 increased significantly
in themmp-2-knockdowned cells, and decreased significantly in
theMMP-2 activated cells (Fig. 3A). By comparison, the protein
level of N-cadherin remained unchanged following modulation
of MMP-2 activity. These results suggest that MMP-2 is
involved in the regulation of ECM and integrins, rather than
N-cadherin, at the mesenchymal cell surface.The cell-to-matrix interaction by fibronectin, and its receptor
integrin β1, initiates the adhesion-mediated mesenchymal
condensation process (Hentschel et al., 2004; White et al.,
2003). FAK is localized to focal adhesions where it is activated
by phosphorylation after integrin-mediated cell attachment
(Chen et al., 2000; Giancotti and Ruoslahti, 1999; Mitra et al.,
2005, 2006). For this reason we investigated whether modula-
tion of protein levels of fibronectin and integrin β1 by MMP-2
affected FAK activation. Mesenchymal cells at 48 h after
treatment of bafilomycin A1 or transfection with the mmp-2
siRNA vector were subjected to SDS-PAGE and immunoblot
analysis with the anti-phospho FAK antibody specific to Tyr
(397), the phosphorylation of which is associated with kinase
Fig. 3. MMP-2 induces down-regulation of ECM molecules at the protein level
and their interaction with FAK. Mesenchymal cells were transfected with the
MMP-2-specific siRNA (si MMP-2) construct or treated with bafilomycin A1
(BA) and harvested after 48 h. (A) Changes in the protein levels of FN, type II
collagen, α5, β1 integrin and N-cadherin during chondrogenesis were analyzed
by Western blotting using respective antibodies. (B) FAK, phosphorylated at
tyrosine (397) site was detected using the anti-phosphotyrosine antibody. (C)
Cell lysates were immunoprecipitated with the anti-integrin β1 antibody, and
subjected to immunoblot analysis with the anti-FAK antibody. (D) Cell lysates
were immunoprecipitated with anti-phosphotyrosine (PY) antibody. Immuno-
blot analysis of immunoprecipitates and cell lysates was performed with anti-
paxillin or c-Src antibodies. GAPDH served as a loading control.
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knockdown of mmp-2, but decreased after activation of MMP-2
by bafilomycin A1 (Fig. 3B). To determine if modulation of
tyrosine phosphorylation of FAK is due to alterations in the
association of FAK at the focal adhesion where fibronectin
interacts with integrin β1, immunoprecipitation assays were
performed on cells 48 h after transfection with the mmp-2
siRNA vector or treatment of bafilomycin A1. Anti-integrin β1
antibody immunoprecipitates were probed with the anti-FAK
antibody. The association of integrin β1 with FAK increasedwith siRNA-mediated knockdown of MMP-2, but decreased on
bafilomycin A1 treatment (Fig. 3C). Adhesion of chondrocytes
to the site of interaction between fibronectin and integrin β1
leads to tyrosine phosphorylation of cytoskeletal and signaling
proteins localized at focal adhesions, including paxillin, c-Src
and FAK (Gemba et al., 2002). The immunoprecipitation assay
using the anti-phospho tyrosine antibody revealed that knock-
down of MMP-2 increased the level of paxillin and c-Src
tyrosine phosphorylation, whereas activation of MMP-2 by
bafilomycin A1 reduced tyrosine phosphorylation of these
proteins (Fig. 3D). These results indicate that the up-regulation
of protein levels of fibronectin and integrin α5/β1 in the
absence of MMP-2 leads to an increases in the tyrosine
phosphorylation of focal adhesion molecules including FAK, c-
Src, and paxillin, through stimulation of the interaction between
FAK and fibronectin via integrin α5/β1. MMP-2-induced
negative regulation of precartilage condensation appears to
involve prevention of the focal adhesion complex assembly.
Integrin-mediated tyrosine phosphorylation of FAK is
essential for precartilage condensation of mesenchymal cells
(Bang et al., 2000; Takahashi et al., 2003). The role of tyrosine
phosphorylation of FAK in the MMP-2-induced inhibition of
cellular condensation was investigated by incubating mesench-
ymal cells with either GM6001, an MMP-2 inhibitor, or
herbimycin A, a tyrosine kinase inhibitor, or with combination
of GM6001 and herbimycin A. Tyrosine phosphorylation of
FAK was significantly increased by GM6001 and significantly
decreased by herbimycin A. Co-treatment of herbimycin A and
GM6001 reversed the GM6001-stimulated phosphorylation of
FAK without a change in the protein level (Fig. 4A).
Precartilage condensation decreased significantly as a result of
inhibition of tyrosine phosphorylation and, as expected,
increased as a result of inhibition of MMP-2 activity.
Herbimycin A also abolished GM6001-promoted cellular
condensation (Fig. 4B). These results indicate that MMP-2
inhibits cellular condensation via the inhibition of tyrosine
phosphorylation of FAK that mediates assembly of focal
adhesion complex at the cell adhesion site.
The cytoskeleton is critical to the formation of the focal
adhesion complexes regulated by the interaction between FAK
and integrin β1 (Bang et al., 2000; Calandrella et al., 2005). We
previously reported that cytochalasin D (CD), an inhibitor of
actin polymerization, inhibits precartilage condensation via
negative regulation of FAK phosphorylation (Bang et al., 2000).
By comparison, insulin-like growth factor-1 (IGF-I), a growth
and survival factor, triggers polymerization of F-actin, induces
phosphorylation of FAK and paxillin, and enhances the
interaction of integrin β1 with these focal adhesion proteins
(Kim et al., 2004a; Sekimoto et al., 2005; Tai et al., 2003). To
further investigate the involvement of MMP-2 in the regulation
of the focal adhesion complex, mesenchymal cells were treated
with CD or IGF-I in the presence or absence of MMP-2
inhibitor. CD treatment remarkably reduced phosphorylation of
FAK, whereas IGF-1 treatment significantly increased phos-
phorylation of FAK (Fig. 4C, upper panel). Cotreatment of cells
with IGF-1 and GM6001 synergistically increased tyrosine
phosphorylation of FAK and precartilage condensation (Fig.
Fig. 4. The relationship between FAK phosphorylation and cell condensation.
Chondrogenic competent cells were incubated with 3 μM GM6001 (GM),
10 μg/ml herbimycin A (HM), 5 μg/ml of cytochalasin D (CD) or 100 ng/ml
IGF-1, for 48 h as indicated. (A and C) Immunoblot analysis of cell lysates was
performed with anti-FAK or anti-phospho FAK antibodies. (B and D) The cells
were stained with PNA at day 3 of culture. The data shown are representative of
at least four independent experiments.
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CD and GM6001 inhibited the GM6001-enhanced tyrosine
phosphorylation of FAK and precartilage condensation (Fig.
4D). These results indicate that MMP-2 is a negative regulator
of tyrosine phosphorylation of focal adhesion components and
acts by modulating the association between fibronectin and
integrins α5 and β1 in response to extracellular signals during
the cellular condensation of leg bud mesenchymal cells.
Involvement of p38MAPK in the down-regulation of MMP-2
Our previous reports have shown that ERK and p38MAPK
regulate mesenchymal cell chondrogenesis by modulating the
expression of cell adhesion molecules including N-cadherin,
fibronectin and integrin α5/β1 (Choi et al., 1995; Oh et al.,
2000). The pathway of MMP-2 and MT1-MMP activation
involves MAPKs, including p38MAPK and ERK (Huang et al.,
2005; Kim et al., 2004b; Munshi et al., 2004; Ruhul Amin et al.,
2003). In the present study we investigated the involvement of
MAPKs in the regulation of chondrogenesis by MMP-2.
Mesenchymal cells were pretreated with PD98059, a specific
inhibitor of MEK or SB203580, a specific inhibitor of
p38MAPK and MMP-2 mRNA levels were analyzed by
semiquantitative PCR and quantitative real time PCR. MMP-2mRNA levels were decreased as a result of p38MAPK
inhibition and not MEK–ERK inhibition (Fig. 5A). Gelatin
zymography also demonstrated the decrease in MMP-2 activity
as a result of p38MAPK inhibition and not MEK–ERK
inhibition (Fig. 5B, upper panel). To clarify whether the
decrease in MMP-2 activity by the inhibition of p38MAPK
activity due to the modification at the post-translational level or
the reduction of MMP-2 mRNA level, we analyzed MMP-2
activity after immunoprecipitation with MMP-2 antibody to get
the same amount of MMP-2 protein. The level of MMP-2
activity was not changed by inhibition of p38MAPK pathway
(Fig. 5B, lower panel). These results indicate that MMP-2 is
regulated at the mRNA expression level but not at the activity
level by the p38MAPK pathway during chondrogenesis.
The effect of SB203580 on mesenchymal cell condensation
was also investigated. Cells were treated with SB203580 for the
indicated time periods and precartilage condensation was
analyzed by PNA staining. The early exposure of cells to
SB203580 resulted in a significant increase in the number of
PNA-bound condensation spots, whereas late exposure of cells
to SB203580 showed little effect (Fig. 5C). These results
suggest that in the process of cellular condensation MMP-2
mediates the inhibitory signals of the p38MAPK pathway. The
effect of enhanced MMP-2 activity as a result of p38MAPK
inhibition on the protein levels of fibronectin, and integrins α5
and β1, and on tyrosine phosphorylation of FAK was
investigated. The inhibition of p38MAPK significantly
increased the protein level of fibronectin, and integrins α5
and β1 at the pre-condensation stage (Fig. 5D). Consistent with
these results, inhibition of p38MAPK promoted the phosphor-
ylation of FAK, and cotreatment with bafilomycin A1 overcame
the inhibition of FAK phosphorylation by bafilomycin A1 (Fig.
5E). Collectively, these results show that MMP-2 mediates the
inhibitory signals of the p38MAPK pathway on the cellular
condensation through the negative regulation of focal adhesion.
Discussion
Chondrogenesis is the earliest phase of skeletal development
involving condensation of mesenchymal cells, the differentia-
tion of mesenchymal cells into chondrocytes, and patterning of
chondrifying tissues into skeletal structures. During condensa-
tion, communication between neighboring cells via adhesion
and ECM molecules, such as type I collagen and fibronectin,
provides important signals for subsequent chondrocytic differ-
entiation. MMPs are candidate molecules for communicating
these signals and mediating the progressive turnover of ECM
molecules. As MMP-2 has wide substrate specificity for
cartilage matrix constituents, we postulate that MMP-2 plays
an important role in the regulation of chondrogenesis. In the
present study, we demonstrate that MMP-2 inhibits cellular
condensation by down-regulating the integrin β1-mediated
interaction between fibronectin and FAK, and tyrosine
phosphorylation of focal adhesion components, such as FAK,
paxillin and c-Src at the focal adhesion site. The p38MAPK
pathway induces the down-regulation of tyrosine phosphoryla-
tion of FAK, via the up-regulation of MMP-2, at the
Fig. 5. MMP-2 mediates the inhibitory signals of p38MAPK. Micromass cultured leg bud mesenchymal cells were cultured in the absence or presence of 10 μM
PD98059 (PD) or 10 μM SB203580 (SB). (A) RT-PCR (upper panel) and quantitative real time RT-PCR (qRT-PCR, lower panel) of cell extracts was performed to
analyze the mRNA levels of mmp-2. Data of qRT-PCR represent the mean±SD (⁎⁎⁎Pb0.0001) of three independent experiments each performed in triplicate. (B)
Conditioned media from PD98059 or SB203580-treated cultures were collected at 24 and 48 h then analyzed by gelatin zymography (upper panel). MMP-2 activity
treated with SB203580 was also analyzed after isolation of MMP-2 protein by using 0.5 μg of MMP-2 antibody (lower panel). (C) The cells were stained with PNA at
day 3 of culture. (D and E) The cell lysates at the indicated time (D) or 48 h after culture (E) were subjected to immunoblot analysis with the respective antibody. The
data shown are representative of at least four independent experiments.
481E.-J. Jin et al. / Developmental Biology 308 (2007) 474–484transcription and protein activity levels, leading to inhibition of
leg bud mesenchymal cell condensation.
Precartilage condensation is a multistep process mediated by
cell adhesion and ECM molecules, leading to cell recruitment,
cell-to-cell contacts, and concomitant changes in cell shape
(DeLise et al., 2000; Knudson and Knudson, 2001; Sandell and
Adler, 1999). In vivo, precartilage condensation is accompaniedby direct cell–cell adhesion after the accumulation of cells at
sites of transiently elevated fibronectin deposits (Hall and
Miyake, 2000). These fibronectin deposits may be degraded by
MMP-2 in the regulation of chondrogenesis. In the present
study, MMP-2 induced the down-regulation of fibronectin and
the fibronectin receptors, integrin α5 and β1, at the pre-
condensation stage and inhibited the subsequent interaction of
482 E.-J. Jin et al. / Developmental Biology 308 (2007) 474–484these proteins with FAK. The MMP-2-induced down-regulation
of the FAK-integrin β1 interaction leads to reduced tyrosine
phosphorylation of focal adhesion components, such as FAK, c-
Src, and paxillin. These results suggest that MMP-2 mediates
the turnover of fibronectin, and its receptor, and is involved in
the regulation of the FAK-integrin β1 interaction.
The modulation of MMP-2 activity by bafilomycin A1 or
GM6001 revealed a different temporal effect on cellular
condensation and chondrogenic differentiation. GM6001, an
inhibitor of MMP-2 activity, increased cellular condensation,
whereas bafilomycin A1, a stimulator of MMP-2 activity,
decreased cellular condensation when leg bud mesenchymal
cells were treated at the pre-condensation stage with GM6001 or
bafilomycin A1. Treatment with GM6001 or bafilomycin A1 at
the post-condensation stage had little or no effect on cellular
condensation or chondrogenesis, indicating that modulation of
fibronectin and its receptor by MMP-2 plays an important role
in the regulation of cellular condensation and chondrocytic
differentiation. As chondroblast cells differentiate into chon-
drocytes, ECM production switches from type I collagen,
fibronectin, and its integrin α5/β1 receptor, to type II collagen
and aggrecan (Cancedda et al., 1995; Silbermann and von der
Mark, 1990). In chondrocytes, the force of tension promotes
ECM adhesion of cells resulting in the inhibition of chon-
drogenesis and the concomitant up-regulation of integrins and
FAK and the down-regulation of type II collagen (Takahashi et
al., 2003). Therefore, cell attachment through ECM molecules
is required for the cellular condensation process, but not for
differentiation into chondrocytes. These findings suggest that
MMP-2 has an inhibitory function in precartilage condensation
rather than in chondrogenic differentiation.
Previous studies indicate that ECM molecules, including
fibronectin and the integrins, are also involved in the regulating
activities of MMP-2 mediated by the ERK pathway in several
cancer cell lines (Hood and Cheresh, 2002; Leroy-Dudal et al.,
2005; Mitra et al., 2003, 2006). Our data show that modulation
of fibronectin and fibronectin receptor, integrin α5/β1 at the
protein level and their association with FAK, resulting in
activation of focal adhesion components for mesenchymal cell
adhesion, is regulated by MMP-2 activity.
MAPK pathway components, including ERK1/2 and p38,
are closely associated with the differentiation of chondrocytes
(Nakamura et al., 1999; Oh et al., 2000: Yoon et al., 2000).
During chondrogenesis of chick limb bud mesenchymal cells,
p38MAPK promotes chondrogenesis by down-regulating the
expression of adhesion molecules at post-precartilage conden-
sation stages (Oh et al., 2000). In the present study the
inactivation of p38MAPK by SB203580 lead to down-
regulation of MMP-2 mRNA and protein, and up-regulation
of adhesion molecules in mesenchymal cells at the pre-
condensation stage. This increase in the level of adhesion
molecules by inactivation of p38MAPK lead to significant
stimulation of tyrosine phosphorylation of FAK and the
subsequent promotion of cellular condensation. These results
suggest that the inhibitory function of p38MAPK in cellular
condensation is mediated by MMP-2, and that MMP-2 activity
is controlled at both the temporal and spatial levels by variousfactors, including integrins and growth factors, during chon-
drogenesis in the developing limb. Taken together, our findings
demonstrate that MMP-2 regulates the association of FAK and
fibronectin via integrin β1, thereby leading to the tyrosine
phosphorylation of focal adhesion components. In summary,
MMP-2 functions as an important mediator of inhibitory signals
from the p38MAPK pathway and functions to regulate cellular
condensation of leg bud mesenchymal cells.
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